Timing of expression of inflammatory mediators in skeletal muscles from mice acutely infected with the RA strain of trypanosoma cruzi

Pathobiology

Volumn 76, Issue 4, 2009, Pages 170-180

  Cutrullis, Romina Andrea ^a   Postan, Miriam ^b   Petray, Patricia Beatriz ^a   Corral, Ricardo Santiago ^a,b  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^b Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

Author keywords

Acute infection; Chagas disease; Chemokines; Inflammation; Skeletal muscles; Trypanosoma cruzi

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CXCL9 CHEMOKINE; GAMMA INTERFERON; MESSENGER RNA; NITRIC OXIDE SYNTHASE; RANTES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOLYSIS; SKELETAL MUSCLE; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS DISEASE; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HEART; INFLAMMATION MEDIATORS; MICE; MICE, INBRED BALB C; MUSCLE, SKELETAL; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, CHEMOKINE; RNA, MESSENGER; TRYPANOSOMA CRUZI;

MUS; TRYPANOSOMA CRUZI;

EID: 67651091575     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218333     Document Type: Article

References (45)

1. Morel CM, Lazdins J:Chagas' disease. Nat Rev Microbiol 2003;1:14-15.
2. DosReis GA:Cell-mediated immunity in ex-per imental Trypanosoma cruzi infection. Parasitol Today 1997;13:335-342.
3. Abrahamsohn IA:Cytokines in innate and acquired immunity to Trypanosoma cruzi infection. Braz J Med Biol Res 1998;31:117-121.
4. Petray P, Rottenberg ME, Grinstein S, Örn A:Release of nitric oxide during the experimental infection with Trypanosoma cruzi. Parasite Immunol 1994;16:193-199.
5. Reyes JL, Terrazas LI, Espinoza B, Cruz-Ro-bles D, Soto V, Rivera-Montoya I, Gómez-García L, Snider H, Satoskar AR, Rodríguez-Sosa M:Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection. Infect Immun 2006;74:3170-3179.
6. Yacoub S, Mocumbi AO, Yacoub MH:Neglected tropical cardiomyopathies:I. Chagas disease:myocardial disease. Heart 2008;94:244-248.
7. Laguens RP, Cossio PM, Diez C, Segal A, Vasquez C, Kreutzer E, Khoury E, Arana RM:Immunopathologic and morphologic studies of skeletal muscle in Chagas' disease. Am J Pathol 1975;80:153-162.
8. Higuchi ML, Benvenuti LA, Martins Reis M, Metzger M:Pathophysiology of the heart in Chagas' disease:current status and new developments. Cardiovasc Res 2003;60:96-107.
9. Teixeira AR, Monteiro PS, Rebelo JM, Arganaraz ER, Vieira D, Lauria-Pires L, Nascimento R, Vexenat CA, Silva AR, Ault SK, Costa JM:Emerging Chagas' disease:trophic network and cycle of transmission of Trypanosoma cruzi from palmtrees in the Amazon. Emerg Infect Dis 2001;7:100-112.
10. Brener Z, Gazzinelli RT:Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int Arch Allergy Immunol 1997;114:103-110.
11. Mirkin GA, Celentano AM, Malchiodi EL, Jones M, González Cappa SM:Different Trypanosoma cruzi strains promote neuromyo-pathic damage mediated by distinct Tlymphocyte subsets. Clin Exp Immunol 1997;107:328-334.
12. Chensue SW:Molecular machinations:che-mokine signals in host-pathogen interactions. Clin Microbiol Rev 2001;14:821-835.
13. Almeida IC, Gazzinelli RT:Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi:structural and functional analyses. J Leukoc Biol 2001;70:467-477.
14. Brown WC, Corral RS:Stimulation of Blymphocytes, macrophages, and dendritic cells by protozoan DNA. Microbes Infect 2002;4:969-974.
15. Teixeira MM, Gazzinelli RT, Silva JS:Che-mokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol 2002;18:262-265.
16. Talvani A, Ribeiro CS, Aliberti JC, Mi-chailowsky V, Santos P, Murta S, Romanha A, Almeida I, Farber J, Lannes-Vieira J, Silva J, Gazzinelli R:Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy:tissue parasitism and endogenous IFN-7 as important determinants of chemo-kine mRNA expression during infection with Trypanosoma cruzi . Microbes Infect 2000;2:851-866.
17. Marino AP, Silva AA, Santos PVA, Pintos LMO, Gazinelli RT, Teixeira MM, Lannes-Vieira J:CC-chemokine receptors:a potential therapeutic target for Trypanosoma cruzi -elicited myocarditis. Mem Inst Oswaldo Cruz 2005;100(suppl 1):93-96.
18. Talvani A, Rocha MOC, Ribeiro AL, Correa-Oliveira R, Teixeira MM:Chemokine receptor expression on the surface of peripheral blood mononuclear cells in Chagas disease. J Infect Dis 2004;189:214-220.
19. Mirkin GA, Jones M, Sanz OP, Rey R, Sica RE, González Cappa SM:Experimental Chagas' disease:electrophysiology and cell composition of the neuromyopathic inflammatory lesions in mice infected with a myo-tropic and a pantropic strain of Trypanosoma cruzi . Clin Immunol Immunopathol 1994;73:69-79.
20. González Cappa SM, Bijovsky SAT, Freilij H, Müller LA, Katzin AM:Aislamiento de una cepa de Trypanosoma cruzi a predominio de formas delgadas en la Argentina. Medicina (B Aires) 1981;41:119-120.
21. Postan M, Dvorak JA, McDaniel JP:Studies of Trypanosoma cruzi clones in inbred mice. I. A comparison of the course of infection of C3H/HEN-mice with two clones isolated from a common source. Am J Trop Med Hyg 1983;32:497-506.
22. Sasaki S, Miura T, Nishikawa S, Yamada K, Hirasue M, Nakane A:Protective role of nitric oxide in Staphylococcus aureus infection in mice. Infect Immun 1998;66:1017-1022.
23. Laucella S, Salcedo R, Castaños-Velez E, Ri-arte A, De Titto EH, Patarroyo M, Örn A, Rottenberg ME:Increased expression and secretion of ICAM-1 during experimental i n fe c t ion w i t h Trypanosoma cruzi. Pa ra site Immunol 1996;18:227-239.
24. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A, Bucala R:MIF is a pituitary-derived cytokine that potentiates lethal endo-toxaemia. Nature 1993;365:756-759.
25. Revelli S, Le Page C, Piaggio E, Wietzerbin J, Bottasso O:Benznidazole, a drug employed in the treatment of Chagas' disease, down-regulates the synthesis of nitrite and cytokines by murine stimulated macrophages. Clin Exp Immunol 1999;118:271-277.
26. Zhang N, Schröppel B, Chen D, Fu S, Hud-kins KL, Zhang H, Murphy BM, Sung RS, Bromberg JS:Adenovirus transduction induces expression of multiple chemokines and chemokine receptors in murine β cells and pancreatic islets. Am J Transplant 2003;3:1230-1241.
27. Nagpal ML, Chen Y, Lin T:Effects of overex-pression of CXCL10 (cytokine-responsive gene-2) on MA-10 mouse Leydig tumor cell steroidogenesis and proliferation. J Endocrinol 2004;183:585-594.
28. Kimura N, Kumamoto T, Kawamura Y, Hi-meno T, Nakamura K, Ueyama H, Arakawa R:Expression of autophagy-associated genes in skeletal muscle:an experimental model of chloroquine-induced myopathy. Pathobiol-ogy 2007;74:169-176.
29. von Kreuter BF, Santos-Buch CA:Pathoim-mune polymyositis induced in C3H/HeJ mice by Trypanosoma cruzi infection. Clin Exp Rheumatol 1986;4:83-89.
30. Molina HA, Cardoni RL, Rimoldi MT:The neuromuscular pathology of experimental Chagas' disease. J Neurol Sci 1987;81:287-300
31. Magalhães-Santos IF, Andrade SG:Participation of cytokines in the necrotic-inflammatory lesions in the heart and skeletal muscles of Calomys callosus infected with Trypanosoma cruzi. Mem Inst Oswaldo Cruz 2005;100:555-561.
32. Hardison JL, Wrightsman RA, Carpenter PM, Lane TE, Manning JE:The chemokines CXCL9 and CXCL10 promote a protective immune response but do not contribute to cardiac inflammation following infection with Trypanosoma cruzi. Infect Immun 2006;74:125-134.
33. De Rossi M, Bernasconi P, Baggi F, de Waal Malefyt R, Mantegazza R:Cytokines and chemokines are both expressed by human myoblasts:possible relevance for the immune pathogenesis of muscle inflammation. Int Immunol 2000;12:1329-1335.
34. Hardison JL, Wrightsman RA, Carpenter PM, Kuziel WA, Lane TE, Manning JE:The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi. Infect Immun 2006;74:135-143.
35. Crema E, de Oliveira Monteiro I, Zainer Gomes MG, Silva AA, Rodrigues Júnior V:Evaluation of cytokines (MIG, IFN-7, TNF-α, IL-4, IL-5 and IL-10) during the different evolutive phases of chagasic esophagopathy. Clin Immunol 2006;119:213-218.
36. Gomes JAS, Bahia-Oliveira LMG, Rocha MOC, Busek SCU, Teixeira MM, Silva JS, Correa-Oliveira R:Type 1 chemokine receptor expression in Chagas correlates with morbidity in cardiac patients. Infect Immun 2005;73:7960-7966.
37. Machado FS, Koyama NS, Carregaro V, Fer-reira BR, Milanezi CM, Teixeira MM, Rossi MA, Silva JS:CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi . J Infect Dis 2005;191:627-636.
38. Warren GL, O' Farrell L, Summan M, Hul-derman T, Mishra D, Luster MI, Kuziel WA, Simeonova PP:Role of CC chemokines in skeletal muscle functional restoration after injury. Am J Physiol Cell Physiol 2004;286:C1031-C1036.
39. Luster AD:Chemokines-chemotactic cyto-kines that mediate inflammation. N Engl J Med 1998;338:436-445.
40. Hesselgesser J, Taub D, Baskar P, Greenberg M, Hoxie J, Kolson DL, Horuk R:Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr Biol 1998;8:595-598.
41. Muńoz-Fernández MA, Fernández MA, Fresno M:Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of in-tracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur J Immunol 1992;22:301-307.
42. Melo de Oliveira G, Diniz RL, Batista W, Batista MM, Bani Correa C, de Araújo-Jorge TC, Henriques-Pons A:Fas ligand-depen-dent inflammatory regulation in acute myocarditis induced by Trypanosoma cruzi infection. Am J Pathol 2007;171:79-86.
43. Rousseau D, Demartino S, A njuère F, Ferr ua B, Fragaki K, Le Fichoux Y, Kubar J:Sustained parasite burden in the spleen of Leishmania infantum - infected BALB/c mice is accompanied by expression of MCP-1 transcripts and lack of protection against challenge. Eur Cytokine Netw 2001;12:340-347.
44. Rodriguez-Sosa M, Rosas LE, Terrazas LI, Lu B, Gerard C, Satoskar AR:CC chemokine receptor 1 enhances susceptibility to Leishmania major during early phase of infection. Immunol Cell Biol 2003;81:114-120.
45. Rosas LE, Barbi J, Lu B, Fujiwara Y, Gerard C, Sanders VM, Satoskar AR:CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection. Eur J Immunol 2005;35:515-523.